Comparison of epidemiological, clinical, and biological features of invasive aspergillosis in neutropenic and nonneutropenic patients: A 6-year survey

Clinical Infectious Diseases

Volumn 43, Issue 5, 2006, Pages 577-584

  Cornillet, A ^a   Camus, C ^a   Nimubona, S ^a   Gandemer, V ^a   Tattevin, P ^a   Belleguic, C ^a   Chevrier, S ^a   Meunier, C ^a   Lebert, C ^a   Aupee M ^a   Caulet Maugendre, S ^a   Faucheux, M ^a   Lelong, B ^a   Leray, E ^a   Guiguen, C ^a   Gangneux, J P ^a  

^a PONTCHAILLOU UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

STEROID;

ADULT; AGED; ASPERGILLOSIS; ASPERGILLUS FLAVUS; ASPERGILLUS FUMIGATUS; ASPERGILLUS NIDULANS; ASPERGILLUS NIGER; ASPERGILLUS TERREUS; ASTHMA; CHILD; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; EPIDEMIC; FEMALE; GIANT CELL ARTERITIS; HEMATOLOGIC MALIGNANCY; HIGH RISK PATIENT; HISTOPATHOLOGY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN TISSUE; INTENSIVE CARE UNIT; LUNG LAVAGE; MAJOR CLINICAL STUDY; MALE; MICROANGIOPATHY; MICROBIOLOGICAL EXAMINATION; MORTALITY; NEUTROPENIA; NONHUMAN; OPPORTUNISTIC INFECTION; ORGAN TRANSPLANTATION; PNEUMONIA; PRIORITY JOURNAL; RECIPIENT; REVIEW; RHEUMATOID ARTHRITIS; RISK FACTOR; SENSITIVITY AND SPECIFICITY; SOLID TUMOR; SYMPTOMATOLOGY;

ADOLESCENT; ADULT; AGED; ANTIBODIES, FUNGAL; ANTIFUNGAL AGENTS; ANTIGENS, FUNGAL; ASPERGILLOSIS; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; MALE; MIDDLE AGED; NEUTROPENIA; RISK FACTORS; TIME FACTORS;

EID: 33747616462     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/505870     Document Type: Review

References (34)

1. Denning DW. Invasive aspergillosis. Clin Infect Dis 1998; 26:781-803; quiz, 804-5.
2. Latge JP. Aspergillus fumigatus and aspergillosis. Clin Microbiol Rev 1999; 12:310-50.
3. Ribaud P, Chastang C, Latge JP, et al. Survival and prognostic factors of invasive aspergillosis after allogeneic bone marrow transplantation. Clin Infect Dis 1999; 28:322-30.
4. Stevens DA, Kan VL, Judson MA, et al. Practice guidelines for diseases caused by Aspergillus. Infectious Diseases Society of America. Clin Infect Dis 2000; 30:696-709.
5. Cornet M, Fleury L, Maslo C, Bernard JF, Brucker G. Epidemiology of invasive aspergillosis in France: a six-year multicentric survey in the Greater Paris area. J Hosp Infect 2002; 51:288-96.
6. Denning DW. Therapeutic outcome in invasive aspergillosis. Clin Infect Dis 1996; 23:608-15.
7. Lin SJ, Schranz J, Teutsch SM. Aspergillosis case-fatality rate: systematic review of the literature. Clin Infect Dis 2001; 32:358-66.
8. Singh N, Paterson DL. Aspergillus infections in transplant recipients. Clin Microbiol Rev 2005; 18:44-69.
9. Caillot D, Mannone L, Kara-Slimane F. Invasive aspergillosis [in French]. Rev Prat 2001; 51:731-7.
10. Herbrecht R, Denning DW, Patterson TF, et al. Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis. N Engl J Med 2002; 347:408-15.
11. Kuhlman JE, Fishman EK, Burch PA, Karp JE, Zerhouni EA, Siegelman SS. CT of invasive pulmonary aspergillosis. AJR Am J Roentgenol 1988; 150:1015-20.
12. Marr KA. New approaches to invasive fungal infections. Curr Opin Hematol 2003; 10:445-50.
13. Shaukat A, Bakri F, Young P, et al. Invasive filamentous fungal infections in allogeneic hematopoietic stem cell transplant recipients after recovery from neutropenia: clinical, radiologie, and pathologic characteristics. Mycopathologia 2005; 159:181-8.
14. Lionakis MS, Kontoyiannis DP. Glucocorticoids and invasive fungal infections. Lancet 2003; 362:1828-38.
15. Allam MF, Del Castillo AS, Diaz-Molina C, Navajas RF. Invasive pulmonary aspergillosis: identification of risk factors. Scand J Infect Dis 2002; 34:819-22.
16. Bouza E, Guinea J, Pelaez T, Perez-Molina J, Alcala L, Munoz P. Work-load due to Aspergillus fumigatus and significance of the organism in the microbiology laboratory of a general hospital. J Clin Microbiol 2005; 43:2075-9.
17. Cornet M, Mallat H, Somme D, et al. Fulminant invasive pulmonary aspergillosis in immunocompetent patients-a two-case report. Clin Microbiol Infect 2003; 9:1224-7.
18. Denning DW. Aspergillosis in "nonimmunocompromised" critically ill patients. Am J Respir Crit Care Med 2004; 170:580-1.
19. Dimopoulos G, Piagnerelli M, Berre J, Eddafali B, Salmon I, Vincent JL. Disseminated aspergillosis in intensive care unit patients: an autopsy study. J Chemother 2003; 15:71-5.
20. Meersseman W, Vandecasteele SJ, Wilmer A, Verbeken E, Peetermans WE, Van Wijngaerden E. Invasive aspergillosis in critically ill patients without malignancy. Am J Respir Crit Care Med 2004; 170:621-5.
21. Petri MG, Konig J, Moecke HP, et al. Epidemiology of invasive mycosis in ICU patients: a prospective multicenter study in 435 non-neutropenic patients. Paul-Ehrlich Society for Chemotherapy, Divisions of Mycology and Pneumonia Research. Intensive Care Med 1997; 23:317-25.
22. Pittet D, Huguenin T, Dharan S, et al. Unusual cause of lethal pulmonary aspergillosis in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1996; 154:541-4.
23. Peter E, Bakri F, Ball DM, Cheney RT, Segal BH. Invasive pulmonary filamentous fungal infection in a patient receiving inhaled corticosteroid therapy. Clin Infect Dis 2002; 35:e54-6.
24. Zhirong Y, Wanqing L, Weihua P. Case reports: invasive pulmonary aspergillosis in non-neutropenic patients treated with liposomal amphotericin B. Mycoses 1999; 42:679-82.
25. Paterson DL. New clinical presentations of invasive aspergillosis in non-conventional hosts. Clin Microbiol Infect 2004; 10(Suppl 1):24-30.
26. Ascioglu S, Rex JH, de Pauw B, et al. Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. Clin Infect Dis 2002; 34:7-14.
27. Walsh TJ, Shoham S, Petraitiene R, et al. Detection of galactomannan antigenemia in patients receiving piperacillin-tazobactam and correlations lations between in vitro, in vivo, and clinical properties of the drug-antigen interaction. J Clin Microbiol 2004; 42:4744-8.
28. Groll AH, Shah PM, Mentzel C, Schneider M, Just-Nuebling G, Huebner K. Trends in the postmortem epidemiology of invasive fungal infections at a university hospital. J Infect 1996; 33:23-32.
29. Chow L, Brown NE, Kunimoto D. An unusual case of pulmonary invasive aspergillosis and aspergilloma cured with voriconazole in a patient with cystic fibrosis. Clin Infect Dis 2002; 35:e106-10.
30. Roselle GA, Kauffman CA. Case report: invasive pulmonary aspergillosis in a nonimmunosuppressed patient. Am J Med Sci 1978; 276:357-61.
31. Rello I, Esandi ME, Mariscal D, Gallego M, Domingo C, Valles J. Invasive pulmonary aspergillosis in patients with chronic obstructive pulmonary disease: report of eight cases and review. Clin Infect Dis 1998; 26:1473-5.
32. Muquim A, Dial S, Menzies D. Invasive aspergillosis in patients with chronic obstructive pulmonary diseases. Can Respir J 2005; 12:199-204.
33. Perfect JR, Cox GM, Lee JY, et al. The impact of culture isolation of Aspergillus species: a hospital-based survey of aspergillosis. Clin Infect Dis 2001; 33:1824-33.
34. Garnacho-Montero J, Amaya-Villar R, Ortiz-Leyba C, et al. Isolation of Aspergillus spp. from the respiratory tract in critically ill patients: risk factors, clinical presentation and outcome. Crit Care 2005; 9: R191-9.